Delivery Order SPE2DB20D1051-SPE2DB24FD5VV
Award Date
10/18/23
Potential Completion Date
10/19/23
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Rytary ER 36.25 mg-145 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,176.60 and a completion date of September 8, 2023. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support...
This federal contract award is for the delivery of RYTARY ER 36.25 MG-145 MG CAP 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $5,446.39. The contract has a firm fixed-price pricing type and a period of performance through May 18, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major...
This federal contract award is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S pharmaceutical product to the Defense Logistics Agency (DLA). The contract, valued at $10,448.56, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a completion date of July 20, 2023 and is a firm fixed-price delivery order. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds a significant...
This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) is a delivery order valued at $2,914.51 for the supply of RYTARY ER 48.75 MG-195 MG capsules. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a firm fixed-price pricing type with a completion date of November 20, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of RYTARY ER 48.75 MG-195 MG capsules. The contract has a ceiling value of $4,484.13 and a completion date of September 23, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen is the prime contractor, and the contract is associated with a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of RYTARY ER 48.75 MG-195 MG capsules. The Firm Fixed Price delivery order, valued at $4,046.18, has a performance period ending on March 31, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Rytary ER 36.25 mg-145 mg capsules. The contract has a ceiling value of $1,629.64 and runs through November 14, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of 100 units of RYTARY ER 23.75 MG-95 MG capsules, made by the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $4,606.39, was awarded by the Defense Logistics Agency (DLA) on November 9, 2022, with an ultimate completion date of November 10, 2022. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, from the Defense Logistics Agency (DLA). The contract, worth $2,988.37, is for the delivery of Rytary ER 48.75 mg-195 mg capsules to support government healthcare programs. The contract has an ultimate completion date of March 11, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of RYTARY ER 36.25 MG-145 MG capsules to the U.S. Department of Defense's Medical Supply Chain. The $10,036.91 Firm Fixed Price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical and has a completion date of September 17, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds several Indefinite Delivery...